Evidence map›Paper›PMID 32872402›Full record

ReviewInternational journal of molecular sciences2020

Endocannabinoid-Epigenetic Cross-Talk: A Bridge toward Stress Coping.

Francesco Rusconi, Tiziana Rubino, Elena Battaglioli

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Evolution Increases Primates Brain Complexity Extending RbFOX1 Splicing Activity to LSD1 Modulation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Francesco RusconiDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano-Via Fratelli Cervi 93, 20090 Segrate (MI), Italy.
Tiziana RubinoDepartment of Biotechnology and Life Sciences, Università degli Studi dell'Insubria-Busto Arsizio (VA), 21052 Busto Arsizio, Italy.
Elena BattaglioliDepartment of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano-Via Fratelli Cervi 93, 20090 Segrate (MI), Italy.
University of Milan · ITUniversity of Insubria · IT

Funding

Fondazione Cariplo 2016-0908
6 · The paper itself

Abstract

There is no argument with regard to the physical and psychological stress-related nature of neuropsychiatric disorders. Yet, the mechanisms that facilitate disease onset starting from molecular stress responses are elusive. Environmental stress challenges individuals' equilibrium, enhancing homeostatic request in the attempt to steer down arousal-instrumental molecular pathways that underlie hypervigilance and anxiety. A relevant homeostatic pathway is the endocannabinoid system (ECS). In this review, we summarize recent discoveries unambiguously listing ECS as a stress coping mechanism. As stress evokes huge excitatory responses in emotional-relevant limbic areas, the ECS limits glutamate release via 2-arachydonilglycerol (2-AG) stress-induced synthesis and retrograde cannabinoid 1 (CB1)-receptor activation at the synapse. However, ECS shows intrinsic vulnerability as 2-AG overstimulation by chronic stress rapidly leads to CB1-receptor desensitization. In this review, we emphasize the protective role of 2-AG in stress-response termination and stress resiliency. Interestingly, we discuss ECS regulation with a further nuclear homeostatic system whose nature is exquisitely epigenetic, orchestrated by Lysine Specific Demethylase 1. We here emphasize a remarkable example of stress-coping network where

Indexed as

Adaptation, PsychologicalAnimalsArachidonic AcidsEndocannabinoidsEpigenesis, GeneticGlutamic AcidGlyceridesHistone DemethylasesHomeostasisHumansReceptor, Cannabinoid, CB1Arachidonic AcidsEndocannabinoidsGlutamic AcidGlyceridesglyceryl 2-arachidonateHistone DemethylasesReceptor, Cannabinoid, CB12-arachidonoylglycerol (2-AG)endocannabinoid systemepigeneticshomeostasisHypothalamus-Pituitary-Adrenocortical (HPA)Lysine Specific Demethylase 1psychiatric disorders

Identifiers

PMID32872402
PMCPMC7504015
OpenAlexW3082314637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.